Centessa Pharmaceuticals ($CNTA) Insider Trading & Smart Money Activity
Centessa Pharmaceuticals plc ($CNTA) has 17 insider trades and 8 13F position changes on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($0), net $0.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 8
- Analyst ratings on file
- 0
CNTA insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · — | 0 / 0 | 3 / 5 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All CNTA insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Brett Zbar | Sell (Disposition to issuer) | 152.57K sh | — | |||||||
| Insider | Gregory WeinhoffChief Business Officer | Sell (Disposition to issuer) | 65.92K sh | — | |||||||
| Insider | Carol Stuckley | Sell (Disposition to issuer) | 296.47K sh | — | |||||||
| Insider | Medicxi Ventures Management (Jersey) Ltd | Sell (Open-market sale) | 19.96M sh | — | |||||||
| Insider | Samarth Kulkarni | Sell (Disposition to issuer) | 296.47K sh | — | |||||||
| Insider | Stephen KanesChief Medical Officer | Sell (Disposition to issuer) | 120K sh | — | |||||||
| Insider | Index Ventures Life Vi (Jersey) L.P. | Sell (Open-market sale) | 9.96M sh | — | |||||||
| Insider | Iqbal HussainChief Legal Officer | Sell (Disposition to issuer) | 123.14K sh | — | |||||||
| Insider | Mathias Hukkelhoven | Sell (Disposition to issuer) | 184K sh | — | |||||||
| Insider | Hedley Mary Lynne | Sell (Disposition to issuer) | 296.47K sh | — | |||||||
| Insider | Arjun Goyal | Sell (Disposition to issuer) | 462.58K sh | — | |||||||
| Insider | Raphael DeferiereChief Accounting Officer | Sell (Disposition to issuer) | 207K sh | — | |||||||
| Insider | De Rubertis Francesco | Sell (Disposition to issuer) | 19.96M sh | — | |||||||
| Insider | John CrowleyChief Financial Officer | Sell (Disposition to issuer) | 1.03M sh | — | |||||||
| Insider | Tia BushChief Technology & Quality Ofc | Sell (Disposition to issuer) | 797.73K sh | — | |||||||
| Insider | Karen AndersonChief People Officer | Sell (Disposition to issuer) | 62.09K sh | — | |||||||
| Insider | Accardi Mario AlbertoChief Executive Officer | Sell (Disposition to issuer) | 243.28K sh | — | |||||||
| 13F | Rtw Investments | Added | +263.34K sh | $83.19M | +0.4% | +0.4% | Read | ||||
| 13F | Pentwater Capital Management | New | +8.17M sh | $330.88M | +0.4% | +0.4% | — | ||||
| 13F | Farallon Capital Management | Reduced | -568.07K sh | $194.76M | +0.4% | +0.4% | — | ||||
| 13F | Caption Management | New | +274.12K sh | $11.10M | +0.4% | +0.4% | — | ||||
| 13F | Avoro Capital Advisors | Reduced | -3.13M sh | $462.93M | +0.4% | +0.4% | Read | ||||
| 13F | Adage Capital Partners Gp, L.L.C. | Reduced | -2.36M sh | $354.95M | +0.4% | +0.4% | — | ||||
| 13F | Adage Capital Partners Gp, L.L.C. | Reduced | -2.36M sh | $361.46M | +0.4% | +0.4% | — | ||||
| 13F | Federated Hermes | Reduced | -292.70K sh | $83M | +0.1% | +0.3% | Read |
1W / 1M / 6M = how CNTA moved from the trade or filing date.
Insider trading in CNTA: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Brett Zbar | 1 | — | Jun 24, 2026 | ||
| Gregory Weinhoff | Chief Business Officer | 1 | — | Jun 24, 2026 | |
| Carol Stuckley | 1 | — | Jun 24, 2026 | ||
| Medicxi Ventures Management (Jersey) Ltd | 1 | — | Jun 24, 2026 | ||
| Samarth Kulkarni | 1 | — | Jun 24, 2026 | ||
| Stephen Kanes | Chief Medical Officer | 1 | — | Jun 24, 2026 | |
| Index Ventures Life Vi (Jersey) L.P. | 1 | — | Jun 24, 2026 | ||
| Iqbal Hussain | Chief Legal Officer | 1 | — | Jun 24, 2026 | |
| Mathias Hukkelhoven | 1 | — | Jun 24, 2026 | ||
| Hedley Mary Lynne | 1 | — | Jun 24, 2026 | ||
| Arjun Goyal | 1 | — | Jun 24, 2026 | ||
| Raphael Deferiere | Chief Accounting Officer | 1 | — | Jun 24, 2026 | |
| De Rubertis Francesco | 1 | — | Jun 24, 2026 | ||
| John Crowley | Chief Financial Officer | 1 | — | Jun 24, 2026 | |
| Tia Bush | Chief Technology & Quality Ofc | 1 | — | Jun 24, 2026 | |
| Karen Anderson | Chief People Officer | 1 | — | Jun 24, 2026 | |
| Accardi Mario Alberto | Chief Executive Officer | 1 | — | Jun 24, 2026 |
Institutions moving CNTA (13F)
Frequently asked questions
Are CNTA insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $0, a net $0.
What is the latest insider trade in CNTA?
Brett Zbar filed a sell (disposition to issuer) of 152.57K sh on Jun 24, 2026.
Which institutions changed their CNTA positions?
Recent 13F filers moving the stock include Adage Capital Partners Gp, L.L.C., Rtw Investments, Pentwater Capital Management, Farallon Capital Management and Caption Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.